JORDONNA BERGERON: Open Payments
NPI 1164968921 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 34 payments from 12 companies in 2025. Trend: 2023 $459 · 2024 $695 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $300 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $196 |
| UCB, Inc. | 3 | $86 |
| Neurelis, Inc. | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
| ARGENX US, INC. | 1 | $24 |
| Biogen, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
Products named: VYNDAQEL, JARDIANCE, ELIQUIS, Fintepla, VALTOCO, CAMZYOS, LEQVIO, KISUNLA.
Industry payments across MI — which companies pay providers there.
